Civilization Ventures Management, Llc — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy.
AI & Machine LearningBiotechDeep TechBoston, US
Shashi Murthy(Executive Officer)Sean Kevlahan(Co-founder & CEO)Thomas X. Neenan(Executive Officer)Thomas Neenan(Co-founder & CBO)
Co-investorsBantam Group
TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Daniel Montoro(Executive Officer, Director)inKarthik Jagadeesh(Executive Officer, Director)Christoph Muus(Director)
BoardDipchand Nishar(Director)Sara Choi(Director)
Co-investorsGeneral CatalystWing
uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.
BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US
AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)
Co-investors7 Gate VenturesAPERTURE Venture PartnersTachles VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.